專注於開拓標靶治療及伴隨診斷 Aptose Biosciences, Inc.(APTO.US)為一家臨床階段的抗腫瘤公司，專注於開拓標靶治療及伴隨診斷，主要係提供一種新的途徑誘導細胞凋亡(計畫性細胞死亡)及個別化治療策略，藉以改善威脅患者生命的癌症。如急性骨髓性白血病(AML)、高危性骨髓發育不良症候群(MDS)及其他 APTO - Aptose Biosciences Inc. - 市場 | 美股 | Anue鉅亨 鉅亨美股頻道提供你最完整的APTO - Aptose Biosciences Inc.、美股公司資料、美股股票代號、美股新聞、股價走勢、技術線圖、財報分析、外資分析師評等、歷史股價、盈餘獲利、重要事件及股利配發。 Aptose Biosciences, Inc. (APTO) Stock Price, Quote ...
Aptose Biosciences - APTO - Stock Price & News | The ... Aptose Biosciences, Inc. Interactive Chart. 1W 1M 3M 6M YTD 1Y 5Y 10Y MAX. Price Vs S&P500. APTO S&P 500 Index News & Analysis: Aptose Biosciences. All Market Moves Earnings. 10-Q: APTOSE BIOSCIENCES INC. - MarketWatch
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology Aptose Biosciences Inc. is a clinical-stage biotechnology company. The company is advancing therapeutics to treat life-threatening cancers, such as acute myeloid 5 May 2020 Stock Market News. Profile. Aptose Biosciences, Inc. Subscribe via RSS · Subscribe
Company Overview. Aptose Biosciences is a clinical-stage biotechnology company developing differentiated therapies to address unmet medical needs in oncology, with a particular focus on hematologic malignancies. Aptose is advancing new therapeutics focused on well validated and novel drug targets on the leading edge of cancer research.
Stock analysis for Aptose Biosciences Inc (APTO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. APS Stock Price | Aptose Biosciences Inc. Stock Quote ... Aptose Biosciences Inc. Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. APTO股票價格和圖表 — NASDAQ:APTO — TradingView 查看即時aptose biosciences inc圖表以追踪其股票的價格行為。查找市場預測，apto財務和市場新聞。 APTO - Aptose Biosciences Inc. - 相關新聞 | 美股 | Anue鉅亨